Researchers: ‘Major Breakthrough’ Drug Reduces Coronavirus Deaths By One-Third

Author image

Tommy Beer   Forbes U.S. Staff

Researchers: ‘Major Breakthrough’ Drug Reduces Coronavirus Deaths By One-Third

A steroid called dexamethasone reduced deaths by up to one-third in severely ill hospitalized patients, according to researchers in England, who announced results from a clinical trial on Tuesday.

KEY FACTS

- According to the study, called the "The Recovery Trial," the drug dexamethasone was administered either orally or through an IV. 

- It reportedly reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen.

- The drug did not appear to help less ill patients - those who don't need help with their breathing.

- The results were described as a "major breakthrough" by scientists directing the Oxford University-led clinical trial. 

- Dexamethasone is a relatively cheap and globally available steroid that is commonly used to reduce inflammation in people suffering from other conditions.

- The study states that a randomized group of 2,104 patients was given 6 milligrams of dexamethasone per day for 10 days, while another group of 4,321 was given standard treatment.

BIG NUMBER

8.1 million: As of Tuesday morning, there have been a total of 8,149,365 confirmed coronavirus cases worldwide, resulting in more than 431,000 deaths. 

CRITICAL QUOTE

"This is the only drug so far that has been shown to reduce mortality, and it reduces it significantly. It's a major breakthrough," said professor Peter Horby, co-lead investigator of the trial.

KEY BACKGROUND

Scientists working on the trial suggested that the drug should immediately become standard care in patients treated in hospitals for the coronavirus. "This is a result that shows that if patients who have Covid-19 and are on ventilators or are on oxygen are given dexamethasone, it will save lives, and it will do so at a remarkably low cost," said Martin Landray, an Oxford University professor who is co-leading the trial. Per the BBC, researchers estimated that if the drug had been used to treat patients in the UK from the very start of the coronavirus outbreak, up to 5,000 lives could have been saved. Dexamethasone purportedly helps stop some of the damage that can occur when the body's immune system goes into overdrive as it tries to fight off the coronavirus. The body's overreaction is called a cytokine storm, which can be fatal.

TANGENT

The Recovery Trial began in March. It initially also included the malaria drug hydroxychloroquine. However, it was determined that the potential benefits of hydroxychloroquine were outweighed by the possibility of serious side effects, including heart issues.

Author image

Tommy Beer   Forbes U.S. Staff

I have had the good fortune of being able to cover the NBA for well over a decade. I’ve had my work published by USA Today, Basketball Insiders, Sports Illustrated, and The New York Times, among other national outlets. I have also been featured as a recurring guest on national radio outlets such as Yahoo! Sports, ESPN Radio and SIRIUS XM. Born and raised, and now based in New York, the Knicks have long been an area of specific concentration. My goal is to provide readers with a nuanced, logical look at the Knicks and the league as a whole.